Featured News

Assessing dyspnea severity can improve cardiopulmonary care

The majority of hospitalists agree that routine dyspnea severity assessment would improve patient care.

Cost of autism care may reach $500 billion by 2025

Researchers estimate that the annual cost of caring for people with autism spectrum disorder could rise to $500 billion to $1 trillion.

Decrease in mortality, hospitalization rates among elderly

Yearly mortality, hospital stays, and inpatient costs have decreased in Medicare patients.

Latest News

Assessing dyspnea severity can improve cardiopulmonary care

Assessing dyspnea severity can improve cardiopulmonary care

The majority of hospitalists agree that routine dyspnea severity assessment would improve patient care.

Cost of autism care may reach $500 billion by 2025

Cost of autism care may reach $500 billion by 2025

Researchers estimate that the annual cost of caring for people with autism spectrum disorder could rise to $500 billion to $1 trillion.

Decrease in mortality, hospitalization rates among elderly

Decrease in mortality, hospitalization rates among elderly

Yearly mortality, hospital stays, and inpatient costs have decreased in Medicare patients.

Affordable health insurance, better health reported from ACA

Affordable health insurance, better health reported from ACA

More Americans have reported access to affordable health insurance and feel they are in better health since the ACA.

Poll indicates many people are unaware of hepatitis B vaccine

Poll indicates many people are unaware of hepatitis B vaccine

More than half of Americans polled were unsure or unaware of the existence of a hepatitis B vaccine.

Health insurance should cover primary care inpatient consultations, says AAFP

Health insurance should cover primary care inpatient consultations, says AAFP

Health insurance companies should considering paying PCP for inpatient consulting services.

FDA approves PCSK9 inhibitor for high cholesterol

FDA approves PCSK9 inhibitor for high cholesterol

The FDA approved Praluent (alirocumab), the first injectable PCSK9 inhibitor for high cholesterol.

New synthetic stimulant "Flakka" has adverse psychiatric effects

New synthetic stimulant "Flakka" has adverse psychiatric effects

"Flakka," a synthetic stimulant, can cause violent and unpredictable behavior.

Physician assistants in Ohio benefit from new bill

Physician assistants in Ohio benefit from new bill

Physician-assistant-to-physician ratio in Ohio projected to increase to better meet patient needs due to passage of Senate Bill 110.

Aspirin use common in people with history of CVD, stroke

Aspirin use common in people with history of CVD, stroke

Approximately 70% of Americans with a history of CVD take aspirin regularly.

Sign Up for Free e-newsletters